ABI Signs Next-Generation Sequencing R&D Deal with Eagle Research and Development
 
Applied Biosystems has continued its next-generation sequencing push with a new R&D alliance with Eagle Research and Development, a Boulder Colo.-based company specializing in biomolecular analysis, ABI said this week.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.